Disclosures for "Developing Novel Therapeutic Agents Targeting NLRP3 Inflammasome Inhibition and Oxidative Stress Mitigation for Epilepsy and Neurodegenerative Disorders"
-
Dr. Singh has nothing to disclose.
-
Dr. Thapa has nothing to disclose.
-
Dr. Haque has nothing to disclose.
-
Ram Sharma has nothing to disclose.
-
The institution of Mukut Sharma has received research support from Midwest Veterans' Biomedical Research Foundation.